Venous Thromboembolism Associated with COVID-19, Dr. Kristi Kelley
As new information continuously develops regarding management of the SARS-CoV-2 virus (COVID-19), healthcare practitioners and those who work closely with patients should be aware of the association between COVID-19 infection and venous thromboembolism (VTE). COVID-19 has been associated with the development of a hypercoagulable state in patients, which can lead to the development of a thromboembolism. VTE are known to cause potentially fatal and debilitating complications. This CE addresses the growing need for increased awareness and understanding of recognizing and treating venous thromboembolism in patients who have been infected with the SARS-CoV-2 virus.
This CE will be delivered in conjunction with Kadijah Edwards and Fuller Currie, PharmD Candidates 2021.
(1) Identify the association between COVID-19 infection and the development of VTE.
(2) Explain the risk factors of VTE.
(3) Recognize the signs and symptoms of DVT and PE.
(4) Compare and contrast the different pharmacologic treatment options and treatment duration for COVID-19 associated VTE.
(5) Identify barriers associated with each treatment option including cost, administration, and monitoring requirements.
- 1.20 ABNAuburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515